These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30290590)

  • 21. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
    Jungert A; Neuhäuser-Berthold M
    Nutr Res; 2013 Aug; 33(8):661-7. PubMed ID: 23890356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in gene expression in vitamin D-deficiency: Down-regulation of liver Cyp7a1 and renal Oat3 in mice.
    Quach HP; Noh K; Hoi SY; Bruinsma A; Groothuis GMM; Li AP; Chow ECY; Pang KS
    Biopharm Drug Dispos; 2018 Feb; 39(2):99-115. PubMed ID: 29243851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of vitamin D: current status.
    DeLuca HF
    Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase.
    Karakelides H; Geller JL; Schroeter AL; Chen H; Behn PS; Adams JS; Hewison M; Wermers RA
    J Bone Miner Res; 2006 Sep; 21(9):1496-9. PubMed ID: 16939409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
    Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
    Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
    Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients.
    Dusilová-Sulková S; Šafránek R; Vávrová J; Horáček J; Pavlíková L; Palička V
    Int Urol Nephrol; 2015 Jan; 47(1):169-76. PubMed ID: 25262147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rat renal 25-hydroxyvitamin D3 1- and 24-hydroxylases: their in vivo regulation.
    Tanaka Y; DeLuca HF
    Am J Physiol; 1984 Feb; 246(2 Pt 1):E168-73. PubMed ID: 6538071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study.
    Amrein K; Sourij H; Wagner G; Holl A; Pieber TR; Smolle KH; Stojakovic T; Schnedl C; Dobnig H
    Crit Care; 2011; 15(2):R104. PubMed ID: 21443793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of 1,25-dihydroxyvitamin D3 production by 1,25-dihydroxyvitamin D3 in the hypocalcaemic rat.
    Tanaka Y; DeLuca HF
    Biochem J; 1983 Sep; 214(3):893-7. PubMed ID: 6312966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling.
    Kaufmann M; Schlingmann KP; Berezin L; Molin A; Sheftel J; Vig M; Gallagher JC; Nagata A; Masoud SS; Sakamoto R; Nagasawa K; Uesugi M; Kottler ML; Konrad M; Jones G
    J Bone Miner Res; 2021 Jul; 36(7):1340-1350. PubMed ID: 33856702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D.
    Young MV; Schwartz GG; Wang L; Jamieson DP; Whitlatch LW; Flanagan JN; Lokeshwar BL; Holick MF; Chen TC
    Carcinogenesis; 2004 Jun; 25(6):967-71. PubMed ID: 14729578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of dietary calcium in the physiology of vitamin D toxicity: excess dietary vitamin D3 blunts parathyroid hormone induction of kidney 1-hydroxylase.
    Beckman MJ; Johnson JA; Goff JP; Reinhardt TA; Beitz DC; Horst RL
    Arch Biochem Biophys; 1995 Jun; 319(2):535-9. PubMed ID: 7786039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolic effects of Cholecalciferol supplementation in kidney stone formers with vitamin D deficiency].
    Vitale C; Tricerri A; Bermond F; Fabbrini L; Guiotto C; Marangella M
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercalcemia Without Hypervitaminosis D During Cholecalciferol Supplementation in Critically Ill Patients.
    Holmes WL; Maish GO; Minard G; Croce MA; Dickerson RN
    Nutr Clin Pract; 2020 Oct; 35(5):933-941. PubMed ID: 31605425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of vitamin D2-fortified bread v. supplementation with vitamin D2 or D3 on serum 25-hydroxyvitamin D metabolites: an 8-week randomised-controlled trial in young adult Finnish women.
    Itkonen ST; Skaffari E; Saaristo P; Saarnio EM; Erkkola M; Jakobsen J; Cashman KD; Lamberg-Allardt C
    Br J Nutr; 2016 Apr; 115(7):1232-9. PubMed ID: 26864127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the mechanism of action of vitamin D3 and 1 alpha-OH D3 under conditions of experimental hypercalcemia.
    Dargiel-Targońska I; Cieślukowski Z; Lorenc RS
    Acta Physiol Pol; 1979; 30(2):313-8. PubMed ID: 223375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy.
    Evans KN; Taylor H; Zehnder D; Kilby MD; Bulmer JN; Shah F; Adams JS; Hewison M
    Am J Pathol; 2004 Sep; 165(3):807-13. PubMed ID: 15331405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No Severe Hypercalcemia with Daily Vitamin D3 Supplementation of up to 30 µg during the First Year of Life.
    Valkama S; Holmlund-Suila E; Enlund-Cerullo M; Rosendahl J; Hauta-Alus H; Helve O; Hytinantti T; Viljakainen H; Andersson S; Mäkitie O
    Horm Res Paediatr; 2017; 88(2):147-154. PubMed ID: 28647736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1α,25-dihydroxyvitamin D₃.
    Wang Y; Zhu J; DeLuca HF
    Am J Physiol Endocrinol Metab; 2015 Feb; 308(3):E201-5. PubMed ID: 25425001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.